Validity in imulliparas of increased β-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation

Nephron

Volumn 72, Issue 4, 1996, Pages 557-563

  Vaillant, P ^a   David, E ^b   Constant, I ^a   Athmani, B ^a   Devulder, G ^a   Fievet, P ^a   Gondry, J ^b   Boulanger, J C ^b   Fardelone, P ^b   Fournier, A ^b  

^a CHG Creil Services de Gynécologie Obstétrique et Néphrologie   (Italy)

^b De Néphrologie et Département d lnformation Médicale   (Italy)

Author keywords

Intrauterine growth retardation; Nulliparas; Prediction; Preeclampsia; Human chorionic gonadotrophin

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AMENORRHEA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NULLIPARA; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; TRISOMY 21;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 9044231765     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188939     Document Type: Article

References (38)

1. Beaufils M, Uzan S. Donsimoni R, Colau JC: Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985:Vol i:840-842.
2. Benigni A. Gregorini G. Frusca T. et al: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl.I Med 1989:321:357-362.
3. Uzan S. Beaufils M, Brcart G. et al: Prevention of fetal growth retardation with low-dose aspirin: Findings of EPREDA trial. Lancet 1991; 337:1427-1431.
4. Schil TE. Pclcg E. Goldenberg M. et al: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989:321:351-356.
5. Dckkcr GA. Sibai BM: Low-dose aspirin in the prevention of prceclampsia and fetal growth retardation: rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993:168:214-217.
6. Viinika K. Hartikaincn-Sorri AKK. Lumrne R. et al: Low dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and new born. Br J Obstet Gynaecol 1993:100: 809-815.
7. Italian Study of Aspirin in Pregnancy. Low dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993:341:396-400.
8. Wallenburg HCS. Decker GA. Makovitz JW. Rotmans P: Low-dose aspirin prevents pregnancy-induced hypertension in preeclampsia in angiotensin-sensitive primiogravidae. Lancet 1986;Vol i:1-3.
9. McParland P. Pearce JM. Chamberlain GVP: Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990;335:1552-1555.
10. Hauth JC. Goldenbcrg RL. Parker CR Jr. et al: Low dose aspirin-therapy to prevent preeclampsia. Am J Obstet Gynecol 1993:168: 1083-1093.
11. Sibai BM, Caritis SN, Thom E, et al: Prevention of prceclampsia with low dose aspirin in healthy nulliparous pregnant women. N Engl J Med 1993:329:1213-1218.
12. Steel SA. Pearce JM. McParland P. Chamber-lain GVP: Early Doppler ultrasound screening in prediction of hypertensive disorders of pregnancy. Lancet 1990:335:1548-1551.
13. CLASP (collaborative low dose aspirin study in pregnancy collaborative group): A randomized trial of low dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. lancet 1994:943:619-629.
14. Greer LA: Pathophysiology of preeclampsia: in Caldsr AA. Dunlop W (eds): Hypertension in High Risk Pregnancy. London. Butterworth. 1992, pp 30-79.
15. Loraine JA. Mathew GD: Chorionic gonadotrophin in toxemias of pregnancy. J Obstet Gynaecol Br Empire 1950;57:542-551.
16. Crosignani PG: Correlation of human chorionic somatomamotropin (hCS) with fetal nutrition: in Josimovich JB (ed): Lactogenic Hormones. Fetal Nutrition and Lactation. New York. Wiley, 1973. pp 203-220.
17. Leroy B. Lcfort F: A propos du poids et de la taille des nouveaux-nés à la naissance. Rev Fr Gynecol Obstet 1971:66:391-396.
18. Muller F. Boue A: A single chorionic gonadotrophin assay for maternal scrum screening for Down's syndrome. Prenal Diagn 1990:10:389-398.
19. Vaillant P. David E. Lemay C. et al: Gonadotrophines chorioniques p plasmatiques entre 14 et 20 semaines d’aménorrhée: un marqueur de l'hypertension gravidique. Presse Méd 1992:30:1413-1418.
20. Gonen R. Perez R, David M, Dar H. Merksamer R, Sharf M: The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstcl Gynecol 1992:80:83-86.
21. Sorensen TK. Williams MA. Zinghcim RW. et al: Elevated second trimester human chorionic gonadotrophin and subsequent pregnancy induced hypertension. Am J Obstet Gynecol 1993:169:834-836.
22. O'Brien WF: Predicting prccclampsia. Obstet Gynecol 1990;75:445-452.
23. Gant NF. Daley GL, Chand S, et al: A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52: 2682-2689.
24. Morris JA, O'Gradv JP, Hamilton CJ. Davidson EC: Vascular reactivity to angiotensin II infusion during gestation. Am J Obstet Gynecol 1978:130:379-384.
25. Onev T. Kaulhausen II: The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. Am J Obstet Gynecol 1982:142:17-20.
26. Gant NF, Chand S, Worley RJ. et al: A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol 1974;120:1-7.
27. Kuntz WD: Supine pressor (roll-over test): An evaluation. Am J Obstet Gynecol 1980:137: 764-768.
28. Phelan JP. Everidge GJ. Wilder TL, Newman C: Is the supine pressor test an adequate means of predicting acute hypertension in pregnancy? Am J Obstet Gynecol 1977; 1159:1452-1455.
29. Greer IA: Ambulatory blood pressure in pregnancy: measurements and machines. Brit J Obstet Gynecol 1993:100:887-889.
30. Kyle PM. Clark SJ. Buckley D. et al: Second trimester ambulatory blood pressure in nullipa-rous pregnancy: A useful screening test for preeclampsia? Br J Obstet Gynaecol 1993:100: 914-919.
31. Ballegeer V, Spitz B, Kieckens L. Moreau H. Van Assche A, Collen D: Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989:161:432-436.
32. Bower S. Schlichter K, Campbell S: Doppler ultrasound screening as part of routine antenatal scanning: Prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993:100:989-994.
33. Newham JP. Evans S. Michael CA. et al: Effects of frequent ultrasound in pregnancy: a randomised controlled trial. Lancet 1993:342: 887-889.
34. Pijnenborg R. Dixon HG, Robertson WB. et al: Trophoblastic invasion ofhuman decidua from 8 to 18 weeks of pregnancy. Placenta 1980:1:3.
35. Fox H: The pathology of extra villous tropho-blast. Arch Anal Cytol Pathol 1983:31:73-74.
36. Khorg TY. De Wolf F. Robertson WB. Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by prccclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986:9:1049-1059.
37. Juniaux E. Jurkovic D. Campbell S, Hustin J: Doppler ultrasonographic featuresofthe developing placental circulation: correlation with anatomic findings. Am J Obstet Gynecol 1992; 166:585-587.
38. Fox H: Effect of hypoxia on trophoblast in organ culture: A morphologic and autographic study. Am J Obstet Gynecol 1970:107:1058-1064